I agree - one more cohort. Three additional months makes sense given the comment of 28 days if everyone starts on day one, buffer 2-3 weeks for late starters, 2-3 weeks for data analysis. Add some more time for holidays, that puts it at 9-12 weeks --> mid/late March.
Judging by other oral titration schemes (Novo Amycretin went 3/6/12/25/50/50 or 6/12/25/50/50/100) it seems like 5mg/10mg/20mg --> 40mg or 50mg would be the added 5th cohort. How do you feel about a 40/50mg final cohort?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.